Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Galli
Michele Moretti

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Clinical Colorectal Cancer|April 12, 2015
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II StudyNicola Personeni, Lorenza Rimassa, Claudio Verusio, et al.
Clinical and Experimental Rheumatology|March 28, 2025
Systemic vasculitis: one year in review 2025Paolo Delvino, Chiara Baldini, Martina Bonacini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trialsNiki Christou, Elisabeth S Bergen, Clemence Canton, et al.
Clinical Lung Cancer|August 1, 2020
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS StudyDiego Cortinovis, Federica Grosso, Luciano Carlucci, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.
Journal of the American Academy of Dermatology|November 17, 2016
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 casesMario Mandalà, Francesca Galli, Laura Cattaneo, et al.
British Journal of Cancer|July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcomaAngiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
International Journal of Cancer|September 3, 2022
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infectionNicla La Verde, Agostino Riva, Maria Silvia Cona, et al.
Cancer Medicine|April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patientsMaria Silvia Cona, Agostino Riva, Davide Dalu, et al.
British Journal of Cancer|September 21, 2019
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancerNicoletta Colombo, Eleonora Zaccarelli, Alessandra Baldoni, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Clinical Colorectal Cancer|April 12, 2015
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II StudyNicola Personeni, Lorenza Rimassa, Claudio Verusio, et al.
Clinical and Experimental Rheumatology|March 28, 2025
Systemic vasculitis: one year in review 2025Paolo Delvino, Chiara Baldini, Martina Bonacini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trialsNiki Christou, Elisabeth S Bergen, Clemence Canton, et al.
Clinical Lung Cancer|August 1, 2020
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS StudyDiego Cortinovis, Federica Grosso, Luciano Carlucci, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.
Journal of the American Academy of Dermatology|November 17, 2016
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 casesMario Mandalà, Francesca Galli, Laura Cattaneo, et al.
British Journal of Cancer|July 31, 2018
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcomaAngiolo Gadducci, Federica Grosso, Giovanni Scambia, et al.
International Journal of Cancer|September 3, 2022
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infectionNicla La Verde, Agostino Riva, Maria Silvia Cona, et al.
Cancer Medicine|April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patientsMaria Silvia Cona, Agostino Riva, Davide Dalu, et al.
British Journal of Cancer|September 21, 2019
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancerNicoletta Colombo, Eleonora Zaccarelli, Alessandra Baldoni, et al.
Pageof 10